Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

LifeStance Health (LFST) Long-Term Debt Issuances (2020 - 2024)

LifeStance Health (LFST) has disclosed Long-Term Debt Issuances for 5 consecutive years, with $287.8 million as the latest value for Q4 2024.

  • On a quarterly basis, Long-Term Debt Issuances rose 778.73% to $287.8 million in Q4 2024 year-over-year; TTM through Dec 2024 was $320.6 million, a 455.06% increase, with the full-year FY2024 number at $287.8 million, up 398.34% from a year prior.
  • Long-Term Debt Issuances was $287.8 million for Q4 2024 at LifeStance Health, up from $32.8 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $287.8 million in Q4 2024 to a low of $9.5 million in Q3 2022.
  • A 5-year average of $110.1 million and a median of $29.5 million in 2021 define the central range for Long-Term Debt Issuances.
  • Peak YoY movement for Long-Term Debt Issuances: crashed 87.98% in 2023, then surged 778.73% in 2024.
  • LifeStance Health's Long-Term Debt Issuances stood at $235.9 million in 2020, then plummeted by 88.89% to $26.2 million in 2021, then decreased by 24.24% to $19.8 million in 2022, then surged by 65.0% to $32.8 million in 2023, then soared by 778.73% to $287.8 million in 2024.
  • Per Business Quant, the three most recent readings for LFST's Long-Term Debt Issuances are $287.8 million (Q4 2024), $32.8 million (Q4 2023), and $25.0 million (Q2 2023).